CIK 0001100682 · Large accelerated filer
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Sign in to watch- Ticker
- CRL
- Exchange
- NYSE
- Industry
- Services-Commercial Physical & Biological Research
- FY end
- Dec 27
- Entity type
- operating
- EIN
- 061397316
- Phone
- 781-222-6000
- Business address
- 251 BALLARDVALE ST, WILMINGTON, MA, 01887
- Former names
- CHARLES RIVER LABORATORIES INTERNATIONAL INC, CHARLES RIVER LABORATORIES HOLDINGS INC
- 4 Shares withheld for taxes Corporate Executive VP & CFO gave up 331 shares (to pay taxes)
- 4 Shares withheld for taxes CEVP, Disc & Safety Assessment gave up 213 shares (to pay taxes)
- 4 Shares withheld for taxes EVP, Corp Strategy & Develop gave up 366 shares (to pay taxes)
- 4 Shares withheld for taxes CSVP&Chief Accounting Officer gave up 112 shares (to pay taxes)
- 4 Shares withheld for taxes Corporate Executive VP & COO gave up 640 shares (to pay taxes)
- 4 Shares withheld for taxes EVP & Chief People Officer gave up 276 shares (to pay taxes)
- 4 Grant or award Director acquired 946 shares (grant or award)
- 4 Grant or award Director acquired 1,465 shares (grant or award)
- 4 Grant or award Director acquired 1,761 shares (grant or award)
- 4 Grant or award Director acquired 1,576 shares (grant or award)
- 4 Grant or award Director acquired 946 shares (grant or award)
- 8-K Event Executive or director change · Shareholder vote results
- 4 Grant or award Director acquired 946 shares (grant or award)
- 4 Planned sale Director sold 140 shares at an average $137.57 ($19,260)
- SD Other Specialized Disclosure
- 4 Planned sale Director sold 140 shares at an average $140.74 ($19,703)
- 4 Open-market sale EVP, Corp Strategy & Develop sold 500 shares at $145.41 ($72,705)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
Page 8 of 123 · 2,446 filings